Report of Foreign Issuer (6-k)

---

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

REPORT OF FOREIGN ISSUER

 

Pursuant to Rule 13a-16 or 15d-16 of

The Securities Exchange Act of 1934 

 

For the month of April 2015

 

PACIFIC THERAPEUTICS LTD.

---

(Translation of registrant’s name into English)

 

409 Granville Street, Suite #1500

Vancouver, BC, V6C-1T2 Canada

Tel: [phone]

Fax: [phone]

---

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F x Form 40-F o

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes o No x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

 

 

 

 

 

1

---

 

 

 

Resignation of Auditor

The Company has accepted the resignation of James Stafford Inc. Chartered Accountants ("Stafford") as auditor of the Company and are currently in discussions with another firm to be its successor and will announce the appointment of the new auditor when finalized. There were no reservations in Stafford’s reports on any of the financial statements of the Company commencing at the beginning of the most recently completed fiscal years and ending on 31, December 2013. There were also no reportable events between the Company and Stafford.

 

 

 

 

 

 

---

 

 

 

SUBMITTED HEREWITH

 

 

Exhibits

 

99.1	News Release dated April 16, 2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

---

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: April 17, 2015

 

 

	PACIFIC THERAPEUTICS LTD
	By:	/s/ Douglas H. Unwin
	Name:	Douglas H. Unwin
	Title:	CEO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3

---

---

EXHIBIT 99.1

 

PACIFIC THERAPEUTICS LTD. ANNOUNCES CHANGE OF AUDITORS

 

VANCOUVER, BC, Canada – April 16, 2015 – Pacific Therapeutics Ltd. (CNSX: PT) (OTC:PCFTF) (Frankfurt: 1P3) (the “Company”) announces that effective April 16, 2015 the Company is in discussions to replace its Auditor.

The Company has accepted the resignation of James Stafford Inc. Chartered Accountants ("Stafford") as auditor of the Company and are currently in discussions with another firm to be its successor and will announce the appointment of the new auditor when finalized. There were no reservations in Stafford’s reports on any of the financial statements of the Company commencing at the beginning of the most recently completed fiscal years and ending on 31, December 2013. There were also no reportable events between the Company and Stafford.

In accordance with NI 51-102, a notice of change of auditor, together with the required letters from the auditor have been filed on SEDAR

 

 

For further information visit our website at www.pacifictherapeutics.com  or email us at [e-mail]

 

Douglas H. Unwin, CEO & President

[phone]

[e-mail]

FORWARD LOOKING STATEMENTS

Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.

 

409 Granville Street Suite 1023, Vancouver, BC V6C 1T2

Ph: [phone]                                                      Fax: [phone]

---